Faculty

Needs Statement

This educational initiative is a component of a grant from the Bureau of Justice Assistance to evaluate data-driven response to prescription drug misuse in Kentucky.

The main objective of this educational initiative is to develop and provide needed continuing education for prescribers and dispensers on the content and interpretation of conviction data within KASPER.

Target Audience

Kentucky prescribers and dispensers that use and interpret the conviction data in KASPER

Objectives

Upon completion of this educational activity, participants will be able to:

• Discuss implications of SB 32 that made drug conviction data available in KASPER effective July 1, 2018
• Review results of Kentucky prescriber and dispenser survey on intent to use drug conviction data in KASPER
• Assess current data regarding the use of drug conviction data in KASPER by prescribers and dispensers

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CPE
This knowledge-based activity will award 1.50 contact hours (0.150 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Other
UK Healthcare CECentral certifies this activity for 1.50 hours of participation.

Faculty Disclosure

The speaker, planners, or reviewers do not have any relevant financial relationships to disclose. 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Acknowledgment

This project was supported by Grant No. 2017-PM-BX-K026 (Data-Driven Responses to Prescription Drug Misuse in Kentucky) awarded by the Bureau of Justice Assistance (BJA) to the Kentucky Injury Prevention and Research Center as bona fide agent for the Kentucky Department for Public Health.

The BJA is a component of the Department of Justice’s Office of Justice Program, which includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office of Victims Crime, and the SMART Office.

Viewpoints or opinions in these programs are those of the authors and do not necessarily represent the official position or policies of the US Department of Justice.